Discover the Future of
Gene Regulation and Regenerative Medicine
We specialize in identifying and developing novel compounds and gene therapies that modulate gene expression to address aging, chronic diseases, inflammation, and tissue regeneration.
At Bio Voyager, we are a cutting-edge biotechnology company founded in 2024 and based in Tampa, Florida. We specialize in identifying and developing novel compounds and gene therapies that modulate gene expression to address aging, chronic diseases, inflammation, and tissue regeneration.
Using advanced High Throughput Screening (HTS) systems and GFP-based promoter-reporter assays in human cell cultures, we rapidly test thousands of substances to discover powerful activators and inhibitors of key genes. We also develop targeted gene therapy solutions using Adeno-Associated Virus (AAV) vectors.
Our work is entirely preclinical — all research is conducted in laboratory settings and is not intended for human use at this stage.
Our Core Services
High-Throughput Screening (HTS) for Gene Modulators
We screen large libraries of compounds (nutraceutical or pharmaceutical) to find highly active molecules that turn genes on or off. Custom or pre-designed screens available Results delivered in 3–6 months Option to license the top 10 most active compounds Pricing starts at $150,000 (nutraceutical-focused) to $250,000 (full screen) + 5% royalty on future net sales.
Our Core Services
Gene Therapy Development
We design, develop, and transfer ready-to-use AAV-based gene therapies for specific targets. Full technology transfer including lab setup and staff training (offshore options available) Timeline: approximately 1 year Pricing starts at $100,000 – $2 Million depending on project scope + 5% royalty on product sales.
Research Partnerships & Licensing
Bring us your target gene or therapeutic goal. We perform discovery work and deliver validated active molecules or gene therapy constructs. Ideal for nutraceutical companies, pharmaceutical developers, and research institutions.
Discover the Future of
Gene Regulation and Regenerative Medicine
At Bio Voyager, we are a cutting-edge biotechnology company founded in 2024 and based in Tampa, Florida. We specialize in identifying and developing novel compounds and gene therapies that modulate gene expression to address aging, chronic diseases, inflammation, and tissue regeneration.
Our Current Research Projects
We are actively advancing multiple high-impact programs.
Each project combines HTS compound discovery with gene therapy approaches where applicable.
JAM2 Activation – Leaky Gut Syndrome
Strengthening intestinal barrier function by increasing JAM2 protein levels.
Approaches: Engineered probiotics, small-molecule activators, and AAV gene therapy.
hTERT Activation – Telomere Extension & Longevity
Reactivating telomerase to lengthen telomeres and promote cellular youth.
Approaches: AAV-hTERT gene therapy and HTS for natural/synthetic activators.
Myostatin Inhibition & Follistatin Activation – Muscle Growth
Suppressing myostatin to remove the natural “brake” on muscle development.
Approaches: Small-molecule inhibitors and AAV gene therapy.
15-Lipoxygenase Inhibition – Mitochondrial & Lipid Health
Reducing oxidative stress and improving energy metabolism.
L
IL-17A Inhibition – Chronic Inflammation
Lowering inflammatory signaling associated with autoimmune conditions.
GSK3 Inhibition – Neuroprotection & Alzheimer’s
Reducing inflammation and supporting brain health.
MC1R Activation – Hair Pigmentation & Gray Hair Reversal
Restoring natural hair color by reactivating melanin pathways.
Myelin Activation – Multiple Sclerosis
Improving nerve insulation and signal transmission.
Fetuin B Activation – Limb Regeneration
Exploring pathways for tissue and limb regrowth.
`
Ready to Partner With Us?
Whether you want to license existing discoveries, commission custom research, or co-develop a gene therapy program, Bio Voyager delivers fast, results-driven biotechnology solutions.
Call Now
312-730-2562
786-307-1256
Email Us
dr.nikolic@ufl.edu